These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3276409)

  • 41. Efficacy of a new accelerated streptokinase regime in acute myocardial infarction: a double blind randomized clinical trial.
    Ghaffari S; Kazemi B; Golzari IG
    Cardiovasc Ther; 2013 Feb; 31(1):53-9. PubMed ID: 21884018
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recombinant hirudin (lepirudin) for the improvement of thrombolysis with streptokinase in patients with acute myocardial infarction: results of the HIT-4 trial.
    Neuhaus KL; Molhoek GP; Zeymer U; Tebbe U; Wegscheider K; Schröder R; Camez A; Laarman GJ; Grollier GM; Lok DJ; Kuckuck H; Lazarus P
    J Am Coll Cardiol; 1999 Oct; 34(4):966-73. PubMed ID: 10520777
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reperfusion therapy in inferior myocardial infarction.
    Bates ER
    J Am Coll Cardiol; 1988 Dec; 12(6 Suppl A):44A-51A. PubMed ID: 3142944
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A randomized trial of intravenous and intracoronary streptokinase in patients with acute myocardial infarction.
    Anderson JL; Marshall HW; Askins JC; Lutz JR; Sorensen SG; Menlove RL; Yanowitz FG; Hagan AD
    Circulation; 1984 Oct; 70(4):606-18. PubMed ID: 6383654
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multicenter reperfusion trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: controlled comparison with intracoronary streptokinase.
    Anderson JL; Rothbard RL; Hackworthy RA; Sorensen SG; Fitzpatrick PG; Dahl CF; Hagan AD; Browne KF; Symkoviak GP; Menlove RL
    J Am Coll Cardiol; 1988 Jun; 11(6):1153-63. PubMed ID: 3284943
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intravenous streptokinase. A reappraisal of its therapeutic use in acute myocardial infarction.
    Goa KL; Henwood JM; Stolz JF; Langley MS; Clissold SP
    Drugs; 1990 May; 39(5):693-719. PubMed ID: 2191849
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early versus late hospital arrival for acute myocardial infarction in the western Washington thrombolytic therapy trials.
    Maynard C; Althouse R; Olsufka M; Ritchie JL; Davis KB; Kennedy JW
    Am J Cardiol; 1989 Jun; 63(18):1296-300. PubMed ID: 2499171
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Primary coronary angioplasty versus intravenous streptokinase in acute myocardial infarction: differences in outcome during a mean follow-up of 18 months.
    Zijlstra F; de Boer MJ; Ottervanger JP; Liem AL; Hoorntje JC; Suryapranata H
    Coron Artery Dis; 1994 Aug; 5(8):707-12. PubMed ID: 8000624
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A double-blind randomized multicenter dose-ranging trial of intravenous streptokinase in acute myocardial infarction.
    Six AJ; Louwerenburg HW; Braams R; Mechelse K; Mosterd WL; Bredero AC; Dunselman PH; van Hemel NM
    Am J Cardiol; 1990 Jan; 65(3):119-23. PubMed ID: 2404388
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of intracoronary streptokinase and intracoronary nitroglycerin infusion on coronary angiographic patterns and mortality in patients with acute myocardial infarction.
    Rentrop KP; Feit F; Blanke H; Stecy P; Schneider R; Rey M; Horowitz S; Goldman M; Karsch K; Meilman H
    N Engl J Med; 1984 Dec; 311(23):1457-63. PubMed ID: 6438504
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Factors affecting outcome of coronary reperfusion with intracoronary streptokinase in acute myocardial infarction.
    Smalling RW; Fuentes F; Matthews MW; Kuhn J; Nishikawa A; Walker WE; Adams PR; Gould KL
    Am J Cardiol; 1987 Mar; 59(6):505-12. PubMed ID: 3548299
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Importance of the early intravenous administration of streptokinase in acute myocardial infarct].
    Martínez Ríos MA; Levy J; Gil Moreno M; Ojeda JL; García P; Cárdenas M; Soní J
    Arch Inst Cardiol Mex; 1988; 58(4):307-11. PubMed ID: 3190366
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [First results of a randomized study of intravenous thrombolytic therapy in acute myocardial infarct--evaluation of the early period].
    Janousek S; Lupínek Z; Toman J; Suchánek M; Chaloupka V; Breinek P; Penka M; Elbl L; Snízková J; Soucek R
    Vnitr Lek; 1988 Dec; 34(12):1145-54. PubMed ID: 3066009
    [No Abstract]   [Full Text] [Related]  

  • 54. Risk stratification for 1 year survival based on characteristics identified in the early hours of acute myocardial infarction. The Western Washington Intracoronary Streptokinase Trial.
    Stadius ML; Davis K; Maynard C; Ritchie JL; Kennedy JW
    Circulation; 1986 Oct; 74(4):703-11. PubMed ID: 3757184
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Coronary artery bypass grafting early after acute myocardial infarction in patients initially treated with thrombolytic therapy or coronary angioplasty.
    Tio RA; de Boer MJ; Hoorntje JC; Suryapranata H; Halebos MM; Zijstra F
    Coron Artery Dis; 1994 Aug; 5(8):713-6. PubMed ID: 8000625
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intravenous streptokinase for acute myocardial infarction. Effects on global and regional systolic function.
    Martin GV; Sheehan FH; Stadius M; Maynard C; Davis KB; Ritchie JL; Kennedy JW
    Circulation; 1988 Aug; 78(2):258-66. PubMed ID: 3396164
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Which patients benefit most from early thrombolytic therapy with intracoronary streptokinase?
    Vermeer F; Simoons ML; Bär FW; Tijssen JG; van Domburg RT; Serruys PW; Verheugt FW; Res JC; de Zwaan C; van der Laarse A
    Circulation; 1986 Dec; 74(6):1379-89. PubMed ID: 3779921
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Atenolol use and clinical outcomes after thrombolysis for acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA (alteplase) for Occluded Coronary Arteries.
    Pfisterer M; Cox JL; Granger CB; Brener SJ; Naylor CD; Califf RM; van de Werf F; Stebbins AL; Lee KL; Topol EJ; Armstrong PW
    J Am Coll Cardiol; 1998 Sep; 32(3):634-40. PubMed ID: 9741504
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical and angiographic features of patients with an occluded versus a patent infarct vessel after intravenous streptokinase for acute myocardial infarction.
    Chouhan L; Hajar HA; George T; Pomposiello JC
    Angiology; 1993 Jun; 44(6):425-31. PubMed ID: 8503507
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Early thrombolysis in acute myocardial infarction: limitation of infarct size and improved survival.
    Simoons ML; Serruys PW; van den Brand M; Res J; Verheugt FW; Krauss XH; Remme WJ; Bär F; de Zwaan C; van der Laarse A
    J Am Coll Cardiol; 1986 Apr; 7(4):717-28. PubMed ID: 2937825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.